Home>
US Stocks>
Helius Medical Technologies

Helius Medical Technologies share price today

(HSDT)

Helius Medical Technologies share price is $0.7 & ₹59.88 as on 30 Dec 2024, 20.30 hrs IST

$0.7

▲

-0.11

(-13.56%)

Market is closed - opens 8 PM, 30 Dec 2024

View live Helius Medical Technologies share price in Dollar and Rupees. Guide to invest in Helius Medical Technologies from India. Also see the sentimental analysis on Indian investors investing in Helius Medical Technologies. Get details on the Indian mutual funds that are investing in Helius Medical Technologies. Get Analyst recommendations and forecasts along with all the Helius Medical Technologies's financials.

Helius Medical Technologies share price movements

Today's Low: $0.66
Today's High: $0.78
$0.70
5.99%
Downside
Day's Volatility :15.9%
Upside
10.54%
52 Weeks Low: $0.37
52 Weeks High: $9.50
$0.70
46.71%
Downside
52 Weeks Volatility :96.07%
Upside
92.63%

Helius Medical Technologies Returns

Period	Helius Medical Technologies Inc	Index (Russel 2000)
3 Months	24.75%	0.0%
6 Months	-28.42%	0.0%
1 Year	-91.34%	0.0%
3 Years	-99.73%	-21.3%

Helius Medical Technologies Key Statistics

in dollars & INR

Previous Close	$0.7
Open	$0.8096
Today's High	$0.7825
Today's Low	$0.65
Market Capitalization	$3.0M
Today's Volume	$624.1K
52 Week High	$9.5
52 Week Low	$0.373
Revenue TTM	$594.0K
EBITDA	$-11.8M
Earnings Per Share (EPS)	$-4.27
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-161.97%

How to invest in Helius Medical Technologies from India?

It is very easy for Indian residents to invest directly in Helius Medical Technologies from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Helius Medical Technologies stock in both Indian Rupees (INR) and US Dollars (USD). Search for Helius Medical Technologies or HSDT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Helius Medical Technologies or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Helius Medical Technologies shares which would translate to 1.222 fractional shares of Helius Medical Technologies as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Helius Medical Technologies, in just a few clicks!

Returns in Helius Medical Technologies for Indian investors in Rupees

Investment Value

₹1,00,000

Helius Medical Technologies investment value today

Current value as on today

₹11,447

Returns

₹88,553

(-88.55%)

Returns from Helius Medical Technologies Stock

₹91,347 (-91.35%)

Dollar Returns

₹2,795 (+2.79%)

Indian investors sentiment towards Helius Medical Technologies

4480.0%

Period: Sep 30, 2024 to Dec 29, 2025. Change in 30 Days versus previous period

Investment in Helius Medical Technologies from India has grown in the last 30 days as on Dec 30, 2025. 4480.0% more purchase transactions for Helius Medical Technologies in the last 30 days versus the previous period.

503%

Period: Sep 30, 2024 to Dec 29, 2025. Change in 30 Days versus previous period

Search volume for Helius Medical Technologies on INDmoney from India has grown in the last 30 days as on Dec 30, 2025. 503% more investors are searching Helius Medical Technologies in the last 30 days versus the previous period.

Global Institutional Holdings in Helius Medical Technologies

Susquehanna International Group, LLP
0.49%
Geode Capital Management, LLC
0.48%
TWO SIGMA SECURITIES, LLC
0.38%
UBS Group AG
0.34%
Vanguard Group Inc
0.34%
Tower Research Capital LLC
0.13%

Analyst Recommendation on Helius Medical Technologies

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Helius Medical Technologies(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Helius Medical Technologies

What analysts predicted

Upside of 471.43%

Current:

$0.70

Target:

$4.00

Insights on Helius Medical Technologies

Price Movement
In the last 7 days, HSDT stock has moved down by -27.1%
Decreasing Revenue
Revenue is down for the last 2 quarters, 182.0K → 51.0K (in $), with an average decrease of 72.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -1.61M → -3.68M (in $), with an average decrease of 128.7% per quarter
HSDT vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 56.8% return, outperforming this stock by 148.1%
HSDT vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 110.9% return, outperforming this stock by 210.6%
Price to Sales
ForHSDT every $1 of sales, investors are willing to pay $1.4, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Helius Medical Technologies Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$478.0K	-
Net Income	$-28.6M	↑ 2.14%
Net Profit Margin	-6.0K%	-

	FY19	Y/Y Change
Revenue	$1.5M	↑ 212.97%
Net Income	$4.3M	↓ 115.16%
Net Profit Margin	290.04%	↑ 6278.12%

	FY20	Y/Y Change
Revenue	$661.0K	↓ 55.82%
Net Income	$-13.9M	↓ 421.2%
Net Profit Margin	-2.1K%	↓ 2398.51%

	FY21	Y/Y Change
Revenue	$522.0K	↓ 21.03%
Net Income	$-18.1M	↑ 30.03%
Net Profit Margin	-3.5K%	↓ 1363.18%

	FY22	Y/Y Change
Revenue	$787.0K	↑ 50.77%
Net Income	$-12.6M	↓ 30.7%
Net Profit Margin	-1.6K%	↑ 1875.97%

	FY23	Y/Y Change
Revenue	$644.0K	↓ 18.17%
Net Income	$-8.9M	↓ 29.53%
Net Profit Margin	-1.4K%	↑ 221.46%

	Q2 FY23	Q/Q Change
Revenue	$256.0K	↑ 130.63%
Net Income	$-1.6M	↑ 52.88%
Net Profit Margin	-643.75%	↑ 327.42%

	Q3 FY23	Q/Q Change
Revenue	$143.0K	↓ 44.14%
Net Income	$-3.7M	↑ 122.27%
Net Profit Margin	-2.6K%	↓ 1917.79%

	Q4 FY23	Q/Q Change
Revenue	$134.0K	↓ 6.29%
Net Income	$-1.0M	↓ 71.47%
Net Profit Margin	-779.85%	↑ 1781.69%

	Q1 FY24	Q/Q Change
Revenue	$135.0K	↑ 0.75%
Net Income	$-2.5M	↑ 140.77%
Net Profit Margin	-1.9K%	↓ 1083.85%

	Q2 FY24	Q/Q Change
Revenue	$182.0K	↑ 34.81%
Net Income	$-1.6M	↓ 35.93%
Net Profit Margin	-885.71%	↑ 977.99%

	Q3 FY24	Q/Q Change
Revenue	$51.0K	↓ 71.98%
Net Income	$-3.7M	↑ 128.66%
Net Profit Margin	-7.2K%	↓ 6341.74%

	FY18	Y/Y Change
Profit	$478.0K	-

	FY19	Y/Y Change
Profit	$650.0K	↑ 35.98%

	FY20	Y/Y Change
Profit	$273.0K	↓ 58.0%

	FY21	Y/Y Change
Profit	$224.0K	↓ 17.95%

	FY22	Y/Y Change
Profit	$324.0K	↑ 44.64%

	FY23	Y/Y Change
Profit	$61.0K	↓ 81.17%

	Q2 FY23	Q/Q Change
Profit	$72.0K	↓ 754.55%

	Q3 FY23	Q/Q Change
Profit	$-44.0K	↓ 161.11%

	Q4 FY23	Q/Q Change
Profit	$36.0K	↓ 181.82%

	Q1 FY24	Q/Q Change
Profit	$5.0K	↓ 86.11%

	Q2 FY24	Q/Q Change
Profit	$64.0K	↑ 1180.0%

	Q3 FY24	Q/Q Change
Profit	$-136.0K	↓ 312.5%

	FY18	Y/Y Change
Operating Cash Flow	$-19.6M	↑ 1.53%
Investing Cash Flow	$-440.0K	↑ 131.58%
Financing Cash Flow	$40.0M	↑ 80.16%

	FY19	Y/Y Change
Operating Cash Flow	$-21.0M	↑ 7.02%
Investing Cash Flow	$-769.0K	↑ 74.77%
Financing Cash Flow	$1.7M	↓ 95.87%

	FY20	Y/Y Change
Operating Cash Flow	$-11.7M	↓ 44.1%
Investing Cash Flow	$-9.0K	↓ 98.83%
Financing Cash Flow	$9.6M	↑ 483.06%

	FY21	Y/Y Change
Operating Cash Flow	$-13.4M	↑ 14.06%
Investing Cash Flow	$-56.0K	↑ 522.22%
Financing Cash Flow	$21.1M	↑ 119.19%

	FY22	Y/Y Change
Operating Cash Flow	$-14.3M	↑ 6.89%
Investing Cash Flow	$-11.0K	↓ 80.36%
Financing Cash Flow	$17.9M	↓ 15.42%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-2.7M	↓ 14.11%
Investing Cash Flow	$-1000.0	↑ 0.0%
Financing Cash Flow	$0.0	-

Helius Medical Technologies Technicals Summary

Sell

Neutral

Buy

Helius Medical Technologies is currently in a neutral trading position according to technical analysis indicators.

Helius Medical Technologies Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Helius Medical Technologies Inc	13.45%	-28.42%	-91.34%	-99.73%	-99.95%
Stryker Corporation	-5.78%	9.1%	23.93%	37.28%	74.44%
Boston Scientific Corp.	0.25%	18.65%	56.74%	113.42%	100.0%
Edwards Lifesciences Corp.	7.26%	-16.18%	0.11%	-41.61%	-2.39%
Abbott Laboratories	-1.56%	11.42%	4.68%	-18.3%	32.25%
Medtronic Plc	-6.7%	4.69%	-2.54%	-21.95%	-29.52%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Helius Medical Technologies Inc	0.14	NA	0.0	-5.64	-1.62	-0.76	NA	3.29
Stryker Corporation	39.51	39.51	2.59	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	75.58	75.58	1.65	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	29.21	29.21	6.97	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.95	34.95	2.23	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.95	24.95	1.49	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Helius Medical Technologies Inc	Buy	$3.0M	-99.95%	0.14	0.0%
Stryker Corporation	Buy	$140.8B	74.44%	39.51	16.34%
Boston Scientific Corp.	Buy	$134.8B	100.0%	75.58	11.26%
Edwards Lifesciences Corp.	Buy	$44.6B	-2.39%	29.21	65.86%
Abbott Laboratories	Buy	$199.4B	32.25%	34.95	13.99%
Medtronic Plc	Buy	$104.6B	-29.52%	24.95	12.06%

About Helius Medical Technologies

helius medical technologies, inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. the company's product is portable neuromodulation stimulator (pons), a medical device in canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. its pons device treats neurostimulation of cranial nerves via the tongue to restore lost function. the company is headquartered in newtown, pennsylvania.

Organization	Helius Medical Technologies
Employees	22
CEO	Mr. Dane Carl Andreeff
Industry	Health Technology

Management People of Helius Medical Technologies

Name	Title
Mr. Dane Carl Andreeff	President, CEO & Director
Mr. Jeffrey S. Mathiesen CPA	CFO, Treasurer, Secretary & Director
Dr. Antonella Favit-Van Pelt M.D., Ph.D.	Chief Medical Officer
Mr. Lawrence Picciano	Senior Vice President of Engineering, Quality & Regulatory Affairs

Important FAQs about investing in Helius Medical Technologies from India :

What is Helius Medical Technologies share price today?

Helius Medical Technologies share price today stands at $0.70, Open: $0.81 ; Previous Close: $0.81 ; High: $0.78 ; Low: $0.66 ; 52 Week High: $9.50 ; 52 Week Low: $0.37. The stock opens at $0.81, after a previous close of $0.81. The stock reached a daily high of $0.78 and a low of $0.66, with a 52-week high of $9.50 and a 52-week low of $0.37.

Can Indians buy Helius Medical Technologies shares?

Yes, Indians can invest in the Helius Medical Technologies (HSDT) from India.

With INDmoney, you can buy Helius Medical Technologies at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Helius Medical Technologies at zero transaction cost.

How can I buy Helius Medical Technologies shares from India?

It is very easy to buy Helius Medical Technologies from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Helius Medical Technologies be purchased?

Yes, you can buy fractional shares of Helius Medical Technologies with INDmoney app.

What are the documents required to start investing in Helius Medical Technologies stocks?

To start investing in Helius Medical Technologies, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.